TSPO ligand-2?

CAS No. 1160640-95-8

TSPO ligand-2?( Carbonic acid )

Catalog No. M28491 CAS No. 1160640-95-8

TSPO ligand-2 is a ligand of AUTAC1 which contains a p-fluorobenzylguanine and a Fumagillol moiety.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 222 Get Quote
10MG 335 Get Quote
25MG 566 Get Quote
50MG 806 Get Quote
100MG 1098 Get Quote
500MG 2205 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TSPO ligand-2?
  • Note
    Research use only, not for human use.
  • Brief Description
    TSPO ligand-2 is a ligand of AUTAC1 which contains a p-fluorobenzylguanine and a Fumagillol moiety.
  • Description
    TSPO ligand-2 is a ligand of AUTAC1 which contains a p-fluorobenzylguanine and a Fumagillol moiety.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Carbonic acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    DNA polymerase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1160640-95-8
  • Formula Weight
    447.48
  • Molecular Formula
    C23H29NO8
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (111.74 mM)
  • SMILES
    C[C@]([C@@]1([H])[C@H](OC)[C@H](OC(OC2=CC=C([N+]([O-])=O)C=C2)=O)CC[C@]13CO3)(O4)[C@H]4C/C=C(C)/C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 11-oxo Mogroside V

    11-oxo Mogroside V is a sweet tasting cucurbitane glycoside derivative of mogroside V. It has antioxidant effects against both O2- and OH- and prevents OH-induced DNA damage.

  • 3-Chloro-L-Tyrosine

    3-Chlorotyrosine a specific marker of myeloperoxidase-catalyzed oxidation is markedly elevated in low-density lipoprotein isolated from human atherosclerotic intima. In particular myeloperoxidase halogenates tyrosine residues in plasma proteins and generates 3-chlorotyrosine (CY).

  • Canertinib

    Canertinib is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo.